Macroaxis considers DelMar Pharmaceuticals to be risky. DelMar Pharmaceuticals
secures Sharpe Ratio (or Efficiency) of -0.3814 which denotes DelMar Pharmaceuticals
had -0.3814% of return per unit of risk over the last 1 month. Macroaxis philosophy towards predicting risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators
. DelMar Pharmaceuticals exposes twenty-one different technical indicators
which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm DelMar Pharmaceuticals Coefficient Of Variation
of 262.21 and Mean Deviation of 2.75 to check risk estimate we provide. Macroaxis gives DelMar Pharmaceuticals performance score of 0 on a scale of 0 to 100. The firm shows Beta (market volatility) of 0.1056 which denotes to the fact that as returns on market increase, DelMar Pharmaceuticals returns are expected to increase less than the market. However during bear market, the loss on holding DelMar Pharmaceuticals will be expected to be smaller as well.. Even though it is essential to pay attention to DelMar Pharmaceuticals historical returns, it is always good to be careful when utilizing equity current trending patterns. Macroaxis philosophy towards predicting future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. DelMar Pharmaceuticals exposes twenty-one different technical indicators which can help you to evaluate its performance. DelMar Pharmaceuticals has expected return of -1.3474%. Please be advised to confirm DelMar Pharmaceuticals Information Ratio as well as the relationship between Value At Risk and Expected Short fall to decide if DelMar Pharmaceuticals past performance will be repeated at some point in the near future.
|15 days auto-correlation|| 0.02 |
Virtually no predictability
DelMar Pharmaceuticals has virtually no predictability. Overlapping area represents the amount of predictability between DelMar Pharmaceuticals time series from June 18, 2018 to July 3, 2018 and July 3, 2018 to July 18, 2018. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DelMar Pharmaceuticals price movement. The serial correlation of 0.02 indicates that only 2.0% of current DelMar Pharmaceuticals price fluctuation can be explain by its past prices.
|Correlation Coefficient|| 0.02|
|Spearman Rank Test|| 0.29|
|Average Price|| 0.67|
|Lagged Average Price|| 0.73|